Skip to content
2000
Volume 22, Issue 3
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

After the emergence of COVID-19 in 2019, it has now become a pandemic. COVID-19 has brought painful disasters to people all over the world. It not only threatens lives and health but also induces economic crises. At present, promising methods to eradicate COVID-19 mainly include drugs and vaccines. Enzyme inhibitors have always been a reliable strategy for the treatment of related diseases. Scientists worldwide have worked together to study COVID-19, obtained the structure of key SARS-CoV-2 associated enzymes, and reported the research of inhibitors of these enzymes. This article summarizes COVID-19-related enzyme inhibitors' recent development, mainly including 3CLpro, PLpro, TMPRSS2, and RdRp inhibitors, hoping to provide valuable weapons in the ensuing battle against COVID-19.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557521666210805104250
2022-02-01
2025-09-01
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557521666210805104250
Loading

  • Article Type:
    Review Article
Keyword(s): 3CLpro; COVID-19; DPP-4; inhibitors; PLpro; RdRp; SARS-CoV-2; TMPRSS2
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test